Abstract
Nasopharyngeal carcinoma is a poorly differentiated upper respiratory tract cancer that highly expresses human folate receptors (hFR). Binding of folate to hFR triggers endocytosis. The folate was conjugated into adenosine 5′-monophosphate (AMP) by 1,6-hexanediamine linkages. After reverse HPLC to reach 93% purity, the folate–AMP, which can only be used for transcription initiation but not for chain extension, was incorporated into the 5′-end of bacteriophage phi29 motor pRNA. A 16:1 ratio of folate–AMP to ATP in transcription resulted in more than 60% of the pRNA containing folate. A pRNA with a 5′-overhang is needed to enhance the accessibility of the 5′ folate for specific receptor binding. Utilizing the engineered left/right interlocking loops, polyvalent dimeric pRNA nanoparticles were constructed using RNA nanotechnology to carry folate, a detection marker, and siRNA targeting at an antiapoptosis factor. The chimeric pRNAs were processed into ds-siRNA by Dicer. Incubation of nasopharyngeal epidermal carcinoma (KB) cells with the dimer resulted in its entry into cancer cells, and the subsequent silencing of the target gene. Such a protein-free RNA nanoparticle with undetectable antigenicity has a potential for repeated long-term administration for nasopharyngeal carcinoma as the effectiveness and specificity were confirmed by ex vivo delivery in the animal trial.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T . Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494–498.
Ryther RC, Flynt AS, Phillips III JA, Patton JG . siRNA therapeutics: big potential from small RNAs. Gene Therapy 2005; 12: 5–11.
Li H, Li WX, Ding SW . Induction and suppression of RNA silencing by an animal virus. Science 2002; 296: 1319–1321.
Brummelkamp TR, Bernards R, Agami R . A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550–553.
Carmichael GG . Medicine: silencing viruses with RNA. Nature 2002; 418: 379–380.
Rossi JJ . Ribozyme therapy for HIV infection. Adv Drug Deliv Rev 2000; 44: 71–78.
Devroe E, Silver PA . Therapeutic potential of retroviral RNAi vectors. Expert Opin Biol Ther 2004; 4: 319–327.
Morrissey DV, Lockridge JA, Shaw L, Blanchard K, Jensen K, Breen W et al. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol 2005; 23: 1002–1007.
Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, Donoghue M et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 2004; 432: 173–178.
Guo P, Erickson S, Anderson D . A small viral RNA is required for in vitro packaging of bacteriophage φ29 DNA. Science 1987; 236: 690–694.
Guo P . Structure and function of phi29 hexameric RNA that drive viral DNA packaging motor: review. Prog Nucl Acid Res Mole Biol 2002; 72: 415–472.
Shu D, Moll D, Deng Z, Mao C, Guo P . Bottom-up assembly of RNA arrays and superstructures as potential parts in nanotechnology. Nano Lett 2004; 4: 1717–1724.
Zhang CL, Lee C-S, Guo P . The proximate 5′ and 3′ ends of the 120-base viral RNA (pRNA) are crucial for the packaging of bacteriophage φ29 DNA. Virology 1994; 201: 77–85.
Chen C, Zhang C, Guo P . Sequence requirement for hand-in-hand interaction in formation of pRNA dimers and hexamers to gear phi29 DNA translocation motor. RNA 1999; 5: 805–818.
Zhang CL, Tellinghuisen T, Guo P . Confirmation of the helical structure of the 5′/3′ termini of the essential DNA packaging pRNA of phage φ29. RNA 1995; 1: 1041–1050.
Hoeprich S, ZHou Q, Guo S, Qi G, Wang Y, Guo P . Bacterial virus phi29 pRNA as a hammerhead ribozyme escort to destroy hepatitis B virus. Gene Therapy 2003; 10: 1258–1267.
Shu D, Huang L, Hoeprich S, Guo P . Construction of phi29 DNA-packaging RNA (pRNA) monomers, dimers and trimers with variable sizes and shapes as potential parts for nano-devices. J Nanosci and Nanotech (JNN) 2003; 3: 295–302.
Lee RJ, Low PS . Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J Biol Chem 1994; 269: 3198–3204.
Mathias CJ, Wang S, Lee RJ, Waters DJ, Low PS, Green MA . Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate. J Nucl Med 1996; 37: 1003–1008.
Benns JM, Maheshwari A, Furgeson DY, Mahato RI, Kim SW . Folate-PEG-folate-graft-polyethylenimine-based gene delivery. J Drug Target 2001; 9: 123–139.
Guo S, Tschammer N, Mohammed S, Guo P . Specific delivery of therapeutic RNAs to cancer cells via the dimerization mechanism of phi29 motor pRNA. Human Gene Ther 2005; 16: 1097–1109.
Khaled A, Guo S, Li F, Guo P . Controllable self-assembly of nanoparticles for specific delivery of multiple therapeutic molecules to cancer cells using RNA nanotechnology. Nano Lett 2005; 5: 1797–1808.
Huang F, Bugg CW, Yarus M . RNA-Catalyzed CoA, NAD, and FAD synthesis from phosphopantetheine, NMN, and FMN. Biochemistry 2000; 39: 15548–15555.
Garver K, Guo P . Boundary of pRNA functional domains and minimum pRNA sequence requirement for specific connector binding and DNA packaging of phage phi29. RNA 1997; 3: 1068–1079.
Seelig B, Jaschke A . Ternary conjugates of guanosine monophosphate as initiator nucleotides for the enzymatic synthesis of 5′-modified RNAs1. Bioconjug Chem 1999; 10: 371–378.
Huang F . Efficient incorporation of CoA, NAD and FAD into RNA by in vitro transcription. Nucleic Acids Res 2003; 31: e8.
Pan T, Gutell RR, Uhlenbeck OC . Folding of circularly permuted transfer RNAs. Science 1991; 254: 1361–1364.
Hoeprich S, Guo P . Computer modeling of three-dimensional structure of DNA-packaging RNA(pRNA) monomer, dimer, and hexamer of Phi29 DNA packaging motor. J Biol Chem 2002; 277: 20794–20803.
Chen C, Sheng S, Shao Z, Guo P . A dimer as a building block in assembling RNA. A hexamer that gears bacterial virus phi29 DNA-translocating machinery. J Biol Chem 2000; 275 (23): 17510–17516.
Carmell MA, Hannon GJ . RNase III enzymes and the initiation of gene silencing. Nat Struct Mol Biol 2004; 11: 214–218.
Guo P, Zhang C, Chen C, Trottier M, Garver K . Inter-RNA interaction of phage phi29 pRNA to form a hexameric complex for viral DNA transportation. Mol Cell 1998; 2: 149–155.
Huang F, Wang G, Coleman T, Li N . Synthesis of adenosine derivatives as transcription initiators and preparation of 5′ fluorescein- and biotin-labeled RNA through one-step in vitro transcription. RNA 2003; 9: 1562–1570.
Acknowledgements
This work was supported mainly by NIH grant R01-EB03730 (Nanoscience and Nanotechnology in Biology and Medicine Program to PG), and partially by NIH grant R01-GM59944 (Institute of General Medicine to PG). We thank Taejin Lee for preparing the data of Figure 4, Philip Low for providing materials and insightful discussions, Paul Robinson for the cytometry assays, Sulma Mohammed for the animal trials, and Jeremy Hall for manuscript preparation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guo, S., Huang, F. & Guo, P. Construction of folate-conjugated pRNA of bacteriophage phi29 DNA packaging motor for delivery of chimeric siRNA to nasopharyngeal carcinoma cells. Gene Ther 13, 814–820 (2006). https://doi.org/10.1038/sj.gt.3302716
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3302716
Keywords
This article is cited by
-
The roles of metallothioneins in carcinogenesis
Journal of Hematology & Oncology (2018)
-
Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology
Molecular Therapy (2016)
-
Self-assembly of free-standing RNA membranes
Nature Communications (2014)
-
Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells
Nature Protocols (2013)
-
Thermodynamically stable RNA three-way junction for constructing multifunctional nanoparticles for delivery of therapeutics
Nature Nanotechnology (2011)